FILTER

FILTERED ARTICLE RESULTS

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

U.S. Pharmaceuticals: The East Coast

July 25, 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.

Serialization Regulations Put Packaging Into the Limelight

April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.

Breaking Down Drug Pricing

April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.

Standing Out in the Biotech Crowd: The VC Investment Climate

February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.

The Indispensable Partner: Contract Services

October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Italy Lifesciences 2021

PARTNER EVENTS